Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 4/20 | 0.42 |
| ▸ | DAO | P14920 | 3/20 | 0.42 |
| ▸ | KDM5A | P29375 | 5/20 | 0.40 |
| ▸ | KDM5C | P41229 | 1/20 | 0.40 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.40 |
| ▸ | GABRA5 | P31644 | 5/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 3/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.36 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30095396 | 0.81 | PARP1 (0.59) | PARP1DAOGABRA5GABRA1POLB | |
| SCHEMBL4763948 | 0.81 | PARP1 (0.59) | PARP1DAOGABRA5GABRA1POLB | |
| SCHEMBL30363017 | 0.79 | PARP1 (0.65) | PARP1DAOGSK3B | |
| SCHEMBL9106684 | 0.79 | PARP1 (0.65) | PARP1DAOGSK3B | |
| SCHEMBL31353069 | 0.76 | TP53 (0.60) | PARP1GABRA5GABRA1POLBCHEK1 | |
| SCHEMBL4039665 | 0.74 | DAO (0.47) | PARP1DAOGABRA5GABRA1 | |
| SCHEMBL2468642 | 0.73 | DAO (0.46) | DAOGABRA5GABRA1 | |
| SCHEMBL7982949 | 0.73 | GABRA5 (0.36) | PARP1DAOGABRA5GABRA1POLB | |
| SCHEMBL29235466 | 0.73 | TP53 (0.46) | PARP1GABRA5GABRA1POLBCHEK1 | |
| SCHEMBL7980241 | 0.73 | DAO (0.46) | PARP1DAOGABRA5GABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1066286-B1 | HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2009-04-29 | — | — | EP | disclosed |
| US-5990109-A | NOVEL COMPOUNDS, METHODS OF THEIR SYNTHESIS, AND THEIR USE IN TREATING VARIOUS TYROSINE KINASE-ASSOCIATED IMMUNOLOGICAL DISORDERS, SUCH AS RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, GRAFT VS. HOST DISEASE, LUPUS, PSORIASIS AND ASTHMA | BRISTOL-MYERS SQUIBB CO. (US) | 1999-11-23 | — | — | US | disclosed |